Potential celiac disease (PCD) is defined by the presence of positive celiac serology, positive tissue transglutaminase antibodies (anti-TTG) and endomysial antibodies (EMA) with a preserved intestinal mucosa without villous atrophy (Marsh grade 0–1). The gene discussed is TGM2; the disease is celiac disease.